Viyash Scientific Ltd

Viyash Scientific Earnings Call: Key Takeaways

Viyash delivered a breakout FY26 with Q4 EBITDA crossing 200cr, marking a successful business integration.

Viyash Scientific Earnings Call: Key Takeaways

Viyash Q4 FY26 revenue reached ₹9,200 Mn with 21.7% EBITDA margins. Management highlights successful integration and a deleveraged balance sheet.

Viyash Scientific Results Update

Viyash Scientific reported FY26 revenues of ₹3,420.3 Crore, with PAT growing 1324%. Strong Q4 performance and merger synergies indicate a solid foundation for future growth.

Value

₹3,420 Cr

Viyash Scientific Q4 FY26 Results: Turns Profitable, Net Profit ₹66.4 Cr

Viyash Scientific Ltd reported revenue from operations of ₹920 Cr (+19.1% YoY) and net profit of ₹66.4 Cr for Q4 FY26.

Key figure

Net profit ₹66.4 Cr

Viyash Scientific Financial Results

Viyash Scientific approved its FY 2025-26 audited financial results and a new employee stock option scheme. No dividend was recommended to conserve resources for growth.

Viyash Scientific Management Change

Viyash Scientific Limited reported the sad demise of Mr. Phillip Trott, AVP – Legal and Compliance. This senior management departure was effective as of May 15, 2026.

Viyash Scientific Board Meeting Date

Viyash Scientific Ltd scheduled a board meeting for May 19, 2026, to approve fiscal 2026 audited financial results. The board will also consider recommending a dividend.

Viyash Scientific Credit Rating

Viyash Scientific Limited received a credit rating upgrade from India Ratings and Research. The long-term rating for INR 35 Crore bank facilities improved to 'IND AA-' with a Stable outlook from 'IND A', while the short-term rating was upgraded to 'IND A1+' from 'IND A1'.

Value

₹35.00 Cr

Viyash Scientific Employee Stock Options

Viyash Scientific Limited allotted 8,000 equity shares at Rs. 86 each under its ESOP 2020 scheme. The allotment, worth approximately ₹0.07 Crore, increases the company's paid-up equity share capital to Rs. 87.37 Crore. These new shares rank pari passu with existing equity.

Value

₹0.07 Cr

Viyash Scientific Credit Rating

Viyash Scientific Ltd has been assigned an '[ICRA]AA- (Stable)' rating for its Rs. 185.00 Crore Long-term Fund Based Working Capital Facilities. This rating from ICRA Limited is higher than the company's previous long-term rating of 'IND A/Positive' issued by India Ratings & Research, reflecting improved creditworthiness.

Value

₹185.0 Cr

Viyash Scientific Management Change

Viyash Scientific Limited has appointed Mr. Amit Jain (Carlyle India Head) and Mr. Abhiroop Jayanthi (Carlyle Managing Director) as Non-Executive Non-Independent Directors effective April 22, 2026. These appointments bring significant private equity and healthcare sector expertise to the board, following a board meeting held on the same day.

Viyash Scientific Management Change

Viyash Scientific Limited has appointed Mr. Amit Jain and Mr. Abhiroop Jayanthi as Non-Executive Non-Independent Directors effective April 22, 2026. Both appointees represent Carlyle India and bring extensive private equity and healthcare sector expertise to the board. These appointments followed a board meeting held on the same day.

Viyash Scientific Board Meeting Outcome

Viyash Scientific Limited appointed Mr. Amit Jain and Mr. Abhiroop Jayanthi as Additional Directors representing the Carlyle Group. The Board also approved a revised ESOP 2026 pool of 1,30,98,000 stock options. These appointments strengthen the company's leadership and strategic ties with Carlyle.

Viyash Scientific Other Announcement

Viyash Scientific Limited (formerly Sequent Scientific Limited) has updated its corporate website to www.viyash.com and its domain to @viyash.com. Consequently, the investor relations email has changed to investorrelations@viyash.com. These changes follow the company's name change and are effective immediately for all official regulatory communications.

Viyash Scientific Other Announcement

Viyash Scientific Limited submitted its quarterly compliance certificate under Regulation 74(5) for the period ended March 31, 2026. Issued by KFin Technologies, the certificate confirms the processing of securities dematerialization and rematerialization requests. This is a routine regulatory filing with no material impact on business operations or financial performance.

Viyash Scientific Employee Stock Options

Viyash Scientific Limited allotted 16,667 equity shares at Rs. 86 per share under its 2020 ESOP plan. This issuance increases the company's paid-up equity capital to Rs. 87.37 Crore. The allotment follows an April 02, 2026, resolution by the Nomination and Remuneration Committee.

Value

₹0.14 Cr